- Price is above Fair Value, showing premium demand versus the model.
- Next-week expectancy is positive at 58.21% based on similar historical setup states.
MEDN
TLV
Week ended 07 Aug 2026
Weekly Investor Report
Mehadrin Ltd · Consumer Defensive · Farm Products
Latest close
279.8 ILA
-3.7%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -10.9% below the Trend Line and sits at 13.8% of its 52-week range. The latest completed week returned -3.7%, after a -4.2% four-week move. The latest news-sentiment score is 53/100.
Setup score
42
out of 100
Latest Close
279.8 ILA
7 Aug 2026
1W Return
-3.7%
latest completed week
4W Return
-4.2%
short-term follow-through
12W Return
-6.7%
quarterly tape
Trend Breadth
88.5%
46 of 52 weeks active
Volume Ratio
1.5x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Activity pressure is negative, which weakens the current setup.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-3.7%
Latest completed week; four-week move -4.2%.
Indicator stack
49/23
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Positive 58.21%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
53/100
4 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -10.9% below the Trend Line and sits at 13.8% of its 52-week range. The latest completed week returned -3.7%, after a -4.2% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.5x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.3712-week average 0.52
12-week confirmation
Trend active6/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure2/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.37Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers
No recent accumulation markers. 2 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -4.2% over four weeks, -6.7% over 12 weeks, and -0.9% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year46
Trend breadth88.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-1.28Latest activity-pressure read.
Pressure change-45.2%Four-week change in activity pressure.
Leadership-17.77Latest relative-leadership reading.
RS change-21.9%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment53/100
Weighted news tone is neutral across 4 relevant articles.
1 positive · 3 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-17.9%Distance below the 52-week high.
13-week volatility3.3%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher13 of 2613 weeks finished lower.
Best week+7.2%Week of 22 May.
Worst week-9.4%Week of 8 May.
Latest week-3.7%Week of 7 Aug.
Shape of recent returns
Strong gains2
Modest gains11
Flat weeks0
Modest losses10
Sharp losses3
Recent vol3.3%13-week weekly-return volatility.
Base vol3.5%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew2.8% / -2.7%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIL Consumer Defensive
4-week rank28 / 34
Group average1.1%
Trend breadth0.0%
Trend0.0%active weekly trend signals
MD0.0%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
IndustryIL Farm Products
4-week rank2 / 3
Group average-10.7%
Trend breadth0.0%
Trend0.0%active weekly trend signals
MD0.0%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape43/100
Trend, activity pressure, participation, and risk combine to a 43/100 tape read.
Indicator analysis27/100Latest 12-week confirmation: trend 6/12, activity pressure 2/12, relative leadership 0/12.
Activity pressure 0.37; 2 reversal markers Next-Week ExpectancyPositive 58.21%Next-week expectancy is positive with a 58.21% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment53/100Weighted news tone is neutral across 4 relevant articles.
Mehadrin Ltd. Revenue Breakdown – TASE:MEDN Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 279.8 ILA | -3.7% | 313.9 ILA | 221.0 ILA | -1.28 | -17.77 | 1.2K | Off |
| 31 Jul 2026 | 290.7 ILA | -3.3% | 315.8 ILA | 220.2 ILA | -1.26 | -14.74 | 593 | Off |
| 24 Jul 2026 | 300.7 ILA | 0.3% | 316.6 ILA | 219.2 ILA | -1.18 | -14.62 | 786 | Off |
| 17 Jul 2026 | 299.7 ILA | 2.6% | 317.2 ILA | 218.2 ILA | -1.15 | -13.43 | 415 | Off |
| 10 Jul 2026 | 292.0 ILA | -3.9% | 317.7 ILA | 217.3 ILA | -0.88 | -14.57 | 2.1K | Off |
| 3 Jul 2026 | 303.9 ILA | -0.4% | 317.8 ILA | 216.2 ILA | -0.54 | -13.05 | 520 | Off |
| 26 Jun 2026 | 305.2 ILA | -4.7% | 317.5 ILA | 215.1 ILA | -0.22 | -10.79 | 0 | On |
| 19 Jun 2026 | 320.2 ILA | -2.8% | 317.1 ILA | 214.0 ILA | 0.10 | -9.15 | 39 | On |
| 12 Jun 2026 | 329.5 ILA | -0.7% | 316.4 ILA | 212.8 ILA | 0.02 | -10.95 | 67 | On |
| 5 Jun 2026 | 331.9 ILA | -0.8% | 315.2 ILA | 211.4 ILA | -0.30 | -8.92 | 67 | On |
| 29 May 2026 | 334.7 ILA | 4.1% | 313.4 ILA | 210.1 ILA | -0.46 | -12.17 | 1.7K | On |
| 22 May 2026 | 321.6 ILA | 7.2% | 312.2 ILA | 208.7 ILA | -0.42 | -14.61 | 1.1K | On |
| 15 May 2026 | 300.0 ILA | -1.9% | 311.4 ILA | 207.4 ILA | -0.22 | -20.47 | 2.1K | On |
| 8 May 2026 | 305.9 ILA | -9.4% | 311.1 ILA | 206.2 ILA | -0.13 | -21.65 | 6.8K | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.